SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Share and Share Alike

The Quest for Transparency for Clinical Trial Data

About this paper

Should life science companies be expected to share patient-level data from their clinical trials? Groups such as the European Medicines Agency and the AllTrials campaign say yes; it's in the public interest to do so. Forward-thinking companies are taking bold steps toward data sharing because it's also good business and good science. This article summarizes discussion on the topic with industry leaders at the Clinical Trial Data Transparency Forum, sponsored by SAS, held in October 2013.

已经注册? 自动完成表格 登录

*
*
*
*
 
*
 
 
  是的,我愿意订阅来自SAS公司及其附属机构的不定期邮件,了解其产品及服务等相关信息。我知道我可以随时通过点击电子邮件中的退订链接取消我的订阅。  

您的个人信息受到 SAS隐私协议 的保护。

 
 

Back to Top